There were no differences in all gene expression before and after anti-cancer therapy in SCC, but JAG1-, JAG2-, and NOTCH2-DEG enrichment significantly increased or decreased after anti-cancer therapy (S17F Fig in S1 File). The gene discussed is JAG1; the disease is cancer.